{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:11:08Z","timestamp":1761052268036,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870105","81770107"],"award-info":[{"award-number":["81870105","81770107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Provincial Health Commission","award":["20201921"],"award-info":[{"award-number":["20201921"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0107800"],"award-info":[{"award-number":["2018YFA0107800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2016zzts165","2017zzts353"],"award-info":[{"award-number":["2016zzts165","2017zzts353"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bcmd.2020.102477","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T02:30:28Z","timestamp":1594693828000},"page":"102477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia"],"prefix":"10.1016","volume":"85","author":[{"given":"Yijin","family":"Kuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanliang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridul","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2020.102477_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2020.102477_bb0010","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic myeloid leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bcmd.2020.102477_bb0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/300765a0","article-title":"A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia","volume":"300","author":"de Klein","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2020.102477_bb0020","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.2147\/IJN.S207298","article-title":"Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL","volume":"14","author":"Wang","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bcmd.2020.102477_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-016-0359-x","article-title":"Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr\/Abl-dependent and Bcr\/Abl-independent mechanisms","volume":"9","author":"Lan","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2020.102477_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-018-0884-z","article-title":"The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcmd.2020.102477_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.leukres.2017.01.005","article-title":"Current approach to the treatment of chronic myeloid leukaemia","volume":"55","author":"Pasic","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2020.102477_bb0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fonc.2019.00603","article-title":"Tyrosine kinase inhibitors available for chronic myeloid leukemia: efficacy and safety","volume":"9","author":"Garcia-Gutierrez","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcmd.2020.102477_bb0045","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1182\/blood-2002-12-3659","article-title":"Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib","volume":"101","author":"Corbin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2020.102477_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yexcr.2017.03.004","article-title":"Nrf-2\/Gst-alpha mediated imatinib resistance through rapid 4-HNE clearance","volume":"353","author":"Wang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcmd.2020.102477_bb0055","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1200\/JCO.2015.64.8899","article-title":"Final 5-year study results of DASISION: the Dasatinib versus Imatinib study in treatment-naive chronic myeloid leukemia patients trial","volume":"34","author":"Cortes","year":"2016","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.bcmd.2020.102477_bb0060","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1002\/jcp.26599","article-title":"CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells","volume":"233","author":"Huang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2020.102477_bb0065","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41375-019-0562-1","article-title":"Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type","volume":"33","author":"Baccarani","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2020.102477_bb0070","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood-2009-08-238360","article-title":"Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia","volume":"116","author":"Bies","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2020.102477_bb0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1590\/1414-431X20143734","article-title":"A combination of STI571 and BCR-ABL1 siRNA with overexpressed p15INK4B induced enhanced proliferation inhibition and apoptosis in chronic myeloid leukemia","volume":"47","author":"Xia","year":"2014","journal-title":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas"},{"key":"10.1016\/j.bcmd.2020.102477_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3727\/096504013X13786659070271","article-title":"Restoration of INK4a\/ARF gene inhibits cell growth and cooperates with imatinib mesylate in Philadelphia chromosome-positive leukemias","volume":"21","author":"Bai","year":"2013","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bcmd.2020.102477_bb0085","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1182\/blood-2007-09-113266","article-title":"P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1","volume":"111","author":"Gilles","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2020.102477_bb0090","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1038\/cddis.2014.388","article-title":"Transcriptional repression of CDKN2D by PML\/RARalpha contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcmd.2020.102477_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2016-09-739268","article-title":"Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis","volume":"129","author":"Han","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2020.102477_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-012-1289-8","article-title":"E2F1 induces p19INK4d, a protein involved in the DNA damage response, following UV irradiation","volume":"366","author":"Carcagno","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bcmd.2020.102477_bb0105","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1523\/JNEUROSCI.4956-06.2007","article-title":"p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis","volume":"27","author":"Laine","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcmd.2020.102477_bb0110","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bbagen.2014.03.015","article-title":"p19INK4d is involved in the cellular senescence mechanism contributing to heterochromatin formation","volume":"1840","author":"Sonzogni","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2020.102477_bb0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1389450120666190809161901","article-title":"p19INK4d: more than just a Cyclin-dependent kinase inhibitor","volume":"21","author":"Han","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcmd.2020.102477_bb0120","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1073\/pnas.1719774115","article-title":"Phosphorylation-induced unfolding regulates p19(INK4d) during the human cell cycle","volume":"115","author":"Kumar","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2020.102477_bb0125","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1093\/hmg\/ddu406","article-title":"p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas","volume":"23","author":"Dreidax","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcmd.2020.102477_bb0130","article-title":"Polypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2020.102477_bb0135","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1128\/MCB.01363-13","article-title":"p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation","volume":"34","author":"Bai","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2020.102477_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.onc.1201185","article-title":"The p19INK4D cyclin dependent kinase inhibitor gene is altered in osteosarcoma","volume":"15","author":"Miller","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2020.102477_bb0145","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1158\/0008-5472.CAN-08-4295","article-title":"Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells","volume":"69","author":"Rao","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2020.102477_bb0150","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1038\/cddis.2014.388","article-title":"Transcriptional repression of CDKN2D by PML\/RAR\u03b1 contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells","volume":"5","author":"Wang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcmd.2020.102477_bb0155","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/leu.2017.253","article-title":"Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants","volume":"31","author":"Hehlmann","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2020.102477_bb0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/leu.2015.36","article-title":"Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV","volume":"29","author":"Kalmanti","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2020.102477_bb0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcmd.2020.102477_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12447","article-title":"Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21(Waf1\/Cip1) and p19(INK4d) upregulation in hepatocellular carcinoma","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bcmd.2020.102477_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1091\/mbc.7.1.57","article-title":"Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4","volume":"7","author":"Guan","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bcmd.2020.102477_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.onc.1201178","article-title":"Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging","volume":"15","author":"Zindy","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2020.102477_bb0185","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1038\/sj.onc.1209459","article-title":"BCR\/ABL and IL-3 activate Rap1 to stimulate the B-Raf\/MEK\/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion","volume":"25","author":"Jin","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2020.102477_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179558","article-title":"Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia","volume":"12","author":"Bandyopadhyay","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2020.102477_bb0195","article-title":"Blockade of Y177 and nuclear translocation of Bcr-Abl inhibits proliferation and promotes apoptosis in chronic myeloid leukemia cells","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2020.102477_bb0200","article-title":"Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2020.102477_bb0205","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2006-09-045039","article-title":"MEK1\/2 inhibitors sensitize Bcr\/Abl+ human leukemia cells to the dual Abl\/Src inhibitor BMS-354\/825","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2020.102477_bb0210","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-15-0393","article-title":"Cellular mechanisms underlying complete hematological response of chronic myeloid leukemia to BRAF and MEK1\/2 inhibition in a patient with concomitant metastatic melanoma","volume":"21","author":"Andrews","year":"2015","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research."},{"key":"10.1016\/j.bcmd.2020.102477_bb0215","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.4049\/jimmunol.164.9.4607","article-title":"Stat3-dependent induction of p19INK4D by IL-10 contributes to inhibition of macrophage proliferation","volume":"164","author":"O\u2019Farrell","year":"2000","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"10.1016\/j.bcmd.2020.102477_bb0220","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/bbrc.1997.7387","article-title":"Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest","volume":"238","author":"Narimatsu","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2020.102477_bb0225","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.onc.1201745","article-title":"Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages","volume":"16","author":"Matsuoka","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2020.102477_bb0230","doi-asserted-by":"crossref","first-page":"11576","DOI":"10.1158\/0008-5472.CAN-07-2756","article-title":"MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells","volume":"67","author":"Kawano","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2020.102477_bb0235","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1172\/JCI85239","article-title":"Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia","volume":"126","author":"Jin","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2020.102477_bb0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbadis.2012.10.014","article-title":"The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl","volume":"1832","author":"Mitra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2020.102477_bb0245","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopha.2011.12.008","article-title":"Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells","volume":"66","author":"Liao","year":"2012","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.bcmd.2020.102477_bb0250","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12943-015-0407-0","article-title":"BCR\/ABL1 and BCR are under the transcriptional control of the MYC oncogene","volume":"14","author":"Sharma","year":"2015","journal-title":"Mol. Cancer"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979620303090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979620303090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:35:25Z","timestamp":1761050125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979620303090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":50,"alternative-id":["S1079979620303090"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2020.102477","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2020.102477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102477"}}